Description
Composition- Vildagliptin SR 100 mg + Dapagliflozin 10 mg + Metformin SR 1000 mg
Mode of Action- Provides triple glycemic control through incretin support, urinary glucose excretion and improved insulin sensitivity with reduced hepatic glucose production.
USPs- Triple mechanism diabetes support; useful in difficult-to-control type 2 diabetes; broad metabolic management.
Prescribing Specialties- Diabetologist, Internal Medicine
